首页|期刊导航|中华医学杂志(英文版)|Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors
中华医学杂志(英文版)2022,Vol.135Issue(12):1404-1413,10.DOI:10.1097/CM9.0000000000002217
Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors
Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors
摘要
关键词
Metastatic sites/Immunotherapy/Liver metastases/Bone metastasis/Non-small-cell lung cancer/Tumor responseKey words
Metastatic sites/Immunotherapy/Liver metastases/Bone metastasis/Non-small-cell lung cancer/Tumor response引用本文复制引用
Jiayi Deng,Qing Zhou,Ming Gao,Qing Gou,Chongrui Xu,Honghong Yan,Mingyi Yang,Jiakang Li,Xiaorong Yang,Xuewu Wei..Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors[J].中华医学杂志(英文版),2022,135(12):1404-1413,10.基金项目
This study was supported by the National Natural Science Foundation of China(No.82072562 to QZ),the High-Level Hospital Construction Project(No.DFJH201810 to QZ),and the GDPH Scientific Research Funds for Leading Medical Talents in Guangdong Province(No.KJ012019428 to QZ). (No.82072562 to QZ)